Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes.
about
Survivin: a unique target for tumor therapyIdentification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide.Survivin in skin pathologies.Multi-target chimaeric VLP as a therapeutic vaccine in a model of colorectal cancer.Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment.
P2860
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes.
@en
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes.
@nl
type
label
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes.
@en
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes.
@nl
prefLabel
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes.
@en
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes.
@nl
P2093
P2860
P356
P1476
Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes.
@en
P2093
Andreas O Eggert
Heike Voigt
Jürgen C Becker
Uta B Hofmann
P2860
P304
P356
10.1002/EJI.200839098
P407
P577
2009-05-01T00:00:00Z